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   A proteolytic enzyme "Varidase Oral" was administered accompanied with antibiotics 
to patients with various urinary tract infections. The results obtained are summarized as 
follows. 
   1. In the cases of non-gonococcal urethritis, the combination of "Varidase Oral" made 
the course required disapperance of morning discharge shortened along with marked im-
provement of microscopic findings. 
   2. In the cases of simple  inflammations such as acute cystitis, the combination therapy 
was not always necessary. Single therapy with antibiotics was sufficiently effective to 
cure the diseases within a short term. 
   3. For chronic pyelonephritis, "Varidase Oral" administration was effective to obtain 
early and marked improvements of urinary findings as well as pyelographic figures. It 
was though that the drug is better to be given along with antibiotics actively from the 
early course of treatment. 
   4. In cases of postoperative fistel formation, the combination therapy made the course 
to close the fistel shortened, although the duration required to eliminate secration was not 
altered. In cases of postoperative cystitis and postoperative refractory infections with 
complications, the therapeutic course was expected to be shortened by the combined ad-
ministration. 
   5. Studies performed before and after the therapy given more than 4 weeks disclosed 

































































菌 を 起炎 菌 とす る も の12例,b)大 腸 菌 を 起炎 菌 とす
る もの8例,c)ブ ドー球 菌 を 起炎 菌 とす る もの2例
の 計22例で あ る.使 用 した 薬 剤 は 起炎 菌 の感 受性 に従
ってWintomylon,Ledermycin,ColimycinS,Sig-
marnycin,Urocydal等で あ る.治 療成 績 はa)群 で
は 早 朝 分泌 物 消 失 日数 は4～48日(平 均26日),早 朝
尿鏡 検 所 見 改 善 日数8～56日(平 均15日),b)群で は
6～41日(平 均16日)お よび10～39日(平 均16日),
c)群 では5～16日(平 均14日)お よび8～24日(平












































































































併用群 プ ロテ ウス













































































































































































腎 下 垂 症





















































































































































































































































































































(本論文 の要 旨は 第14回日本 化 学 療 法 学 会 総 会 に お
いて発表 した.)
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